Novoron Bioscience Competitors and Similar CompaniesClear all
Novoron Bioscience's competitors and similar companies include CTI BioPharma, Palatin Technologies, Sea4Us and Heron Therapeutics.
 Novoron Bioscience Novoron Bioscience is a biotechnology company that develops pharmaceutical therapies to regenerate the nerves of the central nervous system. |  CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. |  Palatin Technologies Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases. |  Sea4Us Sea4Us is a biopharmaceutical company focused on the discovery and development of pharmaceutical drugs based on marine compounds. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | |
Founding Date | Founding Date 2013 | Founding Date 1992 | Founding Date 1986 | Founding Date 2013 | Founding Date 1983 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US | Locations Seattle, US HQ Köln, DE | Locations East Windsor, US HQ | Locations Budens, PT HQ | Locations San Diego, US HQ |
Employees | Employees 166% decrease | Employees 2546% decrease | Employees 185% decrease | Employees 23 | Employees 20333% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 22.5 m | Valuation ($) N/A | Valuation ($) 268.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $53.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.5m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $50.4m (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit $113.6m (FY, 2025) |
Net income | Net income N/A | Net income ($93m) (FY, 2022) | Net income ($17.3m) (FY, 2025) | Net income N/A | Net income ($20.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 1.3m | Total funding raised $ 105m | Total funding raised $ 104.2m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CTI BioPharma
HQ
Seattle, US
Employees
25↓ 46% decrease
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
View companyPalatin Technologies
HQ
East Windsor, US
Employees
18↓ 5% decrease
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
View companySea4Us
HQ
Budens, PT
Employees
23
Sea4Us is a biopharmaceutical company focused on the discovery and development of pharmaceutical drugs based on marine compounds.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company